# CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma

> **NCT06482294** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Università degli Studi di Ferrara** · enrollment: 80 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** Fluticason either Beclometasone or Budesonide

## Key facts

- **NCT ID:** NCT06482294
- **Lead sponsor:** Università degli Studi di Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-18
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482294, "CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06482294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*